Granulocyte Transfusions: A Critical Reappraisal

被引:18
作者
Valentini, Caterina Giovanna [1 ]
Farina, Francesca [2 ]
Pagano, Livio [1 ]
Teofili, Luciana [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Ist Ematol, Largo Francesco Vito 1, I-00168 Rome, Italy
[2] IRCCS San Raffaele, UO Ematol & Trapianto Midollo, Milan, Italy
关键词
Granulocytes; Infections; Individualized medicine; Personalized therapies; COLONY-STIMULATING FACTOR; LIFE-THREATENING INFECTIONS; BLOOD-CELL TRANSFUSIONS; NEUTROPENIC PATIENTS; PEDIATRIC-PATIENTS; MYELOID PROGENITORS; G-CSF; HEMATOLOGICAL MALIGNANCIES; FUNGAL-INFECTIONS; PERIPHERAL-BLOOD;
D O I
10.1016/j.bbmt.2017.07.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Granulocyte transfusions (GTs) are seldom used as a life-saving therapy for neutropenic patients with severe infections. Despite compelling evidence of GT efficacy in retrospective and prospective case series, no study has been successful in demonstrating a definite advantage for recipients in controlled clinical trials. This review critically revises some aspects emerging from past experience that might have weakened the evidence of GT benefits. Some specific issues relevant to the efficacy of this therapeutic approach, such as primary infection, delivered doses and schedules, and immunologic effects of GTs, are discussed. Importantly, the awareness of biologic effects accompanying the transfusion of neutrophils might support their use at standardized doses and may definitely convey significant advantages to the recipient patients. (C) 2017 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:2034 / 2041
页数:8
相关论文
共 76 条
[1]   Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation [J].
Adkins, DR ;
Goodnough, LT ;
Shenoy, S ;
Brown, R ;
Moellering, J ;
Khoury, H ;
Vij, R ;
DiPersio, J .
BLOOD, 2000, 95 (11) :3605-3612
[2]   The value and practicality of granulocyte transfusion: a single oncology centre experience [J].
Al-Tanbal, H. ;
Al Humaidan, H. ;
Al-Nounou, R. ;
Roberts, G. ;
Tesfamichael, K. ;
Owaidah, T. .
TRANSFUSION MEDICINE, 2010, 20 (03) :160-168
[3]  
American Association of Blood Banks, 2016, STANDARDS BLOOD BANK, V30th
[4]   Treatment of severe neutropenic sepsis with granulocyte transfusion in the current era - experience from an adult haematology unit in Singapore [J].
Ang, A. L. ;
Linn, Y. C. .
TRANSFUSION MEDICINE, 2011, 21 (01) :13-24
[5]  
[Anonymous], 2021, J TRANSF MED, DOI DOI 10.5603/JTM.2021.0002
[6]   Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted [J].
Arber, C ;
Bitmansour, A ;
Shashidhar, S ;
Wang, S ;
Tseng, B ;
Brown, JMY .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (09) :1666-1671
[7]   Effect and Safety of Granulocyte Transfusions in Pediatric Patients With Febrile Neutropenia or Defective Granulocyte Functions [J].
Atay, Didem ;
Ozturk, Gulyuz ;
Akcay, Arzu ;
Yanasik, Melek ;
Anak, Sema ;
Devecioglu, Omer .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (06) :E220-E225
[8]  
Averbuch D, 2016, CURR DRUG TARGETS
[9]   Neutrophil function is preserved in a pooled granulocyte component prepared from whole blood donations [J].
Bashir, Saber ;
Stanworth, Simon ;
Massey, Edwin ;
Goddard, Fred ;
Cardigan, Rebecca .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (06) :701-711
[10]   THE EFFECTS OF DAILY RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ADMINISTRATION ON NORMAL GRANULOCYTE DONORS UNDERGOING LEUKAPHERESIS [J].
BENSINGER, WI ;
PRICE, TH ;
DALE, DC ;
APPELBAUM, FR ;
CLIFT, R ;
LILLEBY, K ;
WILLIAMS, B ;
STORB, R ;
THOMAS, ED ;
BUCKNER, CD .
BLOOD, 1993, 81 (07) :1883-1888